DE60119347D1 - Verwendung von chimäres il6-il6r in huntingtonskrankheit - Google Patents
Verwendung von chimäres il6-il6r in huntingtonskrankheitInfo
- Publication number
- DE60119347D1 DE60119347D1 DE60119347T DE60119347T DE60119347D1 DE 60119347 D1 DE60119347 D1 DE 60119347D1 DE 60119347 T DE60119347 T DE 60119347T DE 60119347 T DE60119347 T DE 60119347T DE 60119347 D1 DE60119347 D1 DE 60119347D1
- Authority
- DE
- Germany
- Prior art keywords
- il6r
- chimeric
- huntington disease
- huntington
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000023105 Huntington disease Diseases 0.000 title abstract 2
- 108090001005 Interleukin-6 Proteins 0.000 abstract 1
- 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 abstract 1
- 102000001708 Protein Isoforms Human genes 0.000 abstract 1
- 108010029485 Protein Isoforms Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 108040006858 interleukin-6 receptor activity proteins Proteins 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00120045 | 2000-09-14 | ||
EP00120045 | 2000-09-14 | ||
PCT/EP2001/010442 WO2002022149A1 (en) | 2000-09-14 | 2001-09-10 | Use of il-6r/il-6 chimera in huntington's disease |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60119347D1 true DE60119347D1 (de) | 2006-06-08 |
DE60119347T2 DE60119347T2 (de) | 2007-02-22 |
Family
ID=8169836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60119347T Expired - Lifetime DE60119347T2 (de) | 2000-09-14 | 2001-09-10 | Verwendung von chimäres il6-il6r in huntingtonskrankheit |
Country Status (13)
Country | Link |
---|---|
US (3) | US20040057928A1 (de) |
EP (1) | EP1317273B1 (de) |
JP (1) | JP5030364B2 (de) |
AT (1) | ATE324906T1 (de) |
AU (2) | AU2001291849B2 (de) |
CA (1) | CA2419954C (de) |
CY (1) | CY1105116T1 (de) |
DE (1) | DE60119347T2 (de) |
DK (1) | DK1317273T3 (de) |
ES (1) | ES2262680T3 (de) |
IL (2) | IL154777A0 (de) |
PT (1) | PT1317273E (de) |
WO (1) | WO2002022149A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL147412A0 (en) * | 2001-12-31 | 2002-08-14 | Yeda Res & Dev | The use of il6r/il6 chimera in nerve cell regeneration |
WO2004037281A1 (en) * | 2002-10-24 | 2004-05-06 | The University Of British Columbia | Methods for neuroprotection |
US7553930B2 (en) | 2003-01-06 | 2009-06-30 | Xencor, Inc. | BAFF variants and methods thereof |
CA2527847C (en) * | 2003-06-12 | 2015-09-29 | Yeda Research & Development Co. Ltd | Enhancement of oligodendrocyte differentiation |
WO2005035564A2 (en) | 2003-10-10 | 2005-04-21 | Xencor, Inc. | Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
ME03079B (de) | 2012-06-08 | 2019-01-20 | Alkermes Pharma Ireland Ltd | Durch zirkuläre permutaton modifizierte liganden als agonisten und antagonisten |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5637483A (en) * | 1991-10-04 | 1997-06-10 | Whitehead Institute For Biomedical Research | Irradiated tumor cell vaccine engineered to express GM-CSF |
IL99803A (en) * | 1991-10-20 | 1997-02-18 | Yeda Res & Dev | Pharmaceutical compositions comprising interleukin-6 for the treatment of chronic lymphocytic leukemia and B-cell lymphomas |
US5792900A (en) * | 1991-10-21 | 1998-08-11 | The Trustees Of The University Of Pennsylvania | Compositions and methods for producing and using homogenous neuronal cell transplants |
IL122818A0 (en) * | 1997-07-10 | 1998-08-16 | Yeda Res & Dev | Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof |
DK1895010T3 (da) * | 1997-12-22 | 2011-11-21 | Oxford Biomedica Ltd | Vektorer baseret på virus for infektiøs hesteanæmi (eiav) |
JP4859153B2 (ja) * | 1999-02-25 | 2012-01-25 | 東ソー株式会社 | 新規神経系細胞分化促進剤 |
IL130586A0 (en) * | 1999-06-21 | 2000-06-01 | Yeda Res & Dev | IL6RIL6 chimera for the treatment of demyelinating diseases |
-
2001
- 2001-09-10 AU AU2001291849A patent/AU2001291849B2/en not_active Ceased
- 2001-09-10 US US10/380,427 patent/US20040057928A1/en not_active Abandoned
- 2001-09-10 AU AU9184901A patent/AU9184901A/xx active Pending
- 2001-09-10 AT AT01972039T patent/ATE324906T1/de active
- 2001-09-10 PT PT01972039T patent/PT1317273E/pt unknown
- 2001-09-10 EP EP01972039A patent/EP1317273B1/de not_active Expired - Lifetime
- 2001-09-10 CA CA2419954A patent/CA2419954C/en not_active Expired - Lifetime
- 2001-09-10 JP JP2002526399A patent/JP5030364B2/ja not_active Expired - Fee Related
- 2001-09-10 IL IL15477701A patent/IL154777A0/xx unknown
- 2001-09-10 DE DE60119347T patent/DE60119347T2/de not_active Expired - Lifetime
- 2001-09-10 ES ES01972039T patent/ES2262680T3/es not_active Expired - Lifetime
- 2001-09-10 WO PCT/EP2001/010442 patent/WO2002022149A1/en active IP Right Grant
- 2001-09-10 DK DK01972039T patent/DK1317273T3/da active
-
2003
- 2003-03-06 IL IL154777A patent/IL154777A/en not_active IP Right Cessation
-
2006
- 2006-07-28 CY CY20061101058T patent/CY1105116T1/el unknown
-
2007
- 2007-01-11 US US11/622,284 patent/US20070172454A1/en not_active Abandoned
-
2010
- 2010-03-04 US US12/717,305 patent/US8329654B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IL154777A0 (en) | 2003-10-31 |
EP1317273A1 (de) | 2003-06-11 |
ATE324906T1 (de) | 2006-06-15 |
CA2419954A1 (en) | 2002-03-21 |
US20100166703A1 (en) | 2010-07-01 |
US8329654B2 (en) | 2012-12-11 |
IL154777A (en) | 2010-11-30 |
DK1317273T3 (da) | 2006-09-04 |
US20040057928A1 (en) | 2004-03-25 |
DE60119347T2 (de) | 2007-02-22 |
JP2004508409A (ja) | 2004-03-18 |
ES2262680T3 (es) | 2006-12-01 |
US20070172454A1 (en) | 2007-07-26 |
AU9184901A (en) | 2002-03-26 |
WO2002022149A1 (en) | 2002-03-21 |
CY1105116T1 (el) | 2009-11-04 |
EP1317273B1 (de) | 2006-05-03 |
AU2001291849B2 (en) | 2005-11-24 |
JP5030364B2 (ja) | 2012-09-19 |
PT1317273E (pt) | 2006-09-29 |
CA2419954C (en) | 2012-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107248T1 (el) | Συντηγμενες πρωτεϊνες | |
HK1077518A1 (en) | Peptides that modulate nerve growth factor (ngf) activity, their compositions and use | |
DOP2002000429A (es) | Imidazotriazinas | |
CY1111912T1 (el) | Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων | |
CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
DE69427650D1 (de) | Verbindungen mit wachstumshormon-freisetzenden eigenschaften | |
RS51737B (sr) | Korišćenje inhibitora il-18 | |
CY1109361T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
BRPI0414215A (pt) | tienopirazóis | |
BRPI0409359A (pt) | análogos quiméricos de somatostatina-dopamina | |
ATE363531T1 (de) | Claudin polypeptide | |
DE60228878D1 (de) | Proteine mit il-6 inhibitorischer wirkung | |
CY1105116T1 (el) | Χρηση των il-6r/il-6 χιμαιρων στη νοσο του huntington | |
SE0102147D0 (sv) | New methods | |
DK1228097T3 (da) | Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge | |
BR0012291A (pt) | Fenoxifluorpirimidinas | |
RS11104A (en) | Combined preparations,containing 1,4- benzothiepine-1,1- dioxide derivatives and other active substances, and the use thereof | |
DK1331940T3 (da) | Anvendelse af det lange pentraxin PTX3 til behandling af sygdomme forårsaget af ændret aktivering af vækstfaktoren FGF-2 | |
DK1185293T3 (da) | IL6RIL6-kimær til behandling af neurodegenerative sygdomme | |
DE60125232D1 (de) | Kleines säurelösliches sporenprotein und seine verwendungen | |
CY1106363T1 (el) | Χρηση του ενepγοποιημενου παραγοντα πηξης vii για την αγωγη των επαγομενων απο θρομβολυτικη θepαπεια μειζονων αιμορραγιων | |
RS51316B (sr) | Nova upotreba (r)-(-)-2-/5-(4-fluorofenil)-3- piridilmetilaminometil/-hromana i njegovih fiziološki prihvatljivih soli | |
DK1012286T3 (da) | Allelvariant af humant STAT3 | |
EA200600314A1 (ru) | Использование растворимого cd164 при воспалительных и/или аутоимунных нарушениях | |
DE60124093D1 (de) | S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |